Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Chinese Acupuncture & Moxibustion ; (12): 799-802, 2022.
Article in Chinese | WPRIM | ID: wpr-939535

ABSTRACT

Acupuncture regulating gastrointestinal motility has the characteristics of bidirectional benign regulation, acupoint specificity and immediacy. And its regulation is mainly achieved through the "neuro-endocrine-immune" network system. Acupuncture at Neiguan (PC 6) and Hegu (LI 4) to inhibit intestinal peristalsis may have good application value in colonoscopy.


Subject(s)
Acupuncture Points , Acupuncture Therapy , Colonoscopy , Gastrointestinal Motility , Peristalsis
2.
Acta Pharmaceutica Sinica ; (12): 210-213, 2002.
Article in Chinese | WPRIM | ID: wpr-312008

ABSTRACT

<p><b>AIM</b>To study the pharmacokinetics and relative bioavailability of probucol inclusion complex capsule.</p><p><b>METHODS</b>Following oral administration of a single dose of 250 mg of conventional tablet (formulation A, purchased from the market) and probucol inclusion complex capsule (formulation B, a new formulation for preclinical trial) to each of 6 healthy dogs in a randomized crossover design, the plasma levels of the active drug at different time points were determined by HPLC and the plasma concentration-time profiles of formulation A and B were obtained. The pharmacokinetic parameters as well as relative bioavailability were analyzed.</p><p><b>RESULTS</b>The concentration-time curves of formulation A and formulation B were found to fit a two-compartment open model. The Tmax values of formulation A and formulation B were (9.3 +/- 2.1) h and (9.3 +/- 2.1) h, the Cmax values were (1.5 +/- 1.0) microgram.mL-1 and (2.3 +/- 0.9) microgram.mL-1 and the AUC0-240 values were (85 +/- 56) microgram.h.mL-1 and (134 +/- 55) microgram.h.mL-1, respectively. The relative bioavailability of formulation B was found to be (198 +/- 90)% compared with formulation A. The results of variance analysis and two one-side t-test showed that there was significant difference between the two formulations in the AUC0-240.</p><p><b>CONCLUSION</b>The high bioavailability by the inclusion of formulation B is attributed to the improvement of its water-solubility by the inclusion process and this is supposed to be a key factor for improving drug bioavailability.</p>


Subject(s)
Animals , Dogs , Female , Administration, Oral , Anticholesteremic Agents , Pharmacokinetics , Biological Availability , Capsules , Probucol , Pharmacokinetics , Random Allocation , Tablets
SELECTION OF CITATIONS
SEARCH DETAIL